Nucleic acid therapeutics market was valued at $4.1 billion in 2021, and is estimated to reach $12.2 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031. The basic polymers deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) have been extensively studied over the past two decades and are now being considered as …
Continue reading “Nucleic Acid Therapeutics Market Expected to Reach $12.2 Billion by 2031”